Richard Dana Ono insider trades: Lipocine (LPCN) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Richard reports to the SEC
Open-market buys and sales
3 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 20, 2023 | LPCN | ↑ Buy | 4,000 | $0.34 | $1K | Direct | Mar 20, 2023 (0d) |
| Dec 29, 2017 | LPCN | ↓ Sell10b5-1 | 875 | $3.47 | $3K | Direct | Jan 2, 2018 (4d) |
| Nov 19, 2014 | LPCN | ↑ Buy | 4,000 | $5.14 | $21K | Direct | Nov 19, 2014 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other LPCN insiders
Open-market trades in the last 12 months
About Richard Dana Ono's insider trades
Richard Dana Ono is a director at Lipocine (LPCN). Since Nov 19, 2014, Richard has reported 2 open-market purchases worth $22K and 1 sale worth $3K on SEC Form 4. There have been no open-market trades in the last 12 months.
1 sale (100% of the value sold) was made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so it says little about how the insider sees the stock today.
Their filings also include grants and awards (19 filings), option exercises (3 filings), shares withheld for taxes (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every LPCN insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.